Overview
Revolade Tablets contain Eltrombopag 25 mg, a thrombopoietin receptor agonist used to treat thrombocytopenia (low platelet count) in conditions like chronic immune thrombocytopenia (ITP), hepatitis C-associated thrombocytopenia, and aplastic anemia. It works by stimulating the bone marrow to increase platelet production, reducing the risk of bleeding and bruising.





